Albertsons Reaches $774 Million Opioid Settlement

Levin Papantonio Attorneys Among Legal Team Driving Pharmacy Accountability

Apr. 15, 2026 at 1:35am

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring an arrangement of glass bottles, pill bottles, and medical supplies in shades of blue, grey, and white, conceptually representing the corporate and public health implications of the opioid crisis.A carefully curated studio still life captures the complex intersection of corporate accountability and public health in the wake of the opioid epidemic.Pensacola Today

Albertsons Companies, Inc. has reached a $774 million settlement framework to resolve opioid-related claims brought by state, local and tribal governments across the country. The settlement, to be paid out over nine years, represents one of the most significant financial accountability measures yet imposed on a major pharmacy chain for its role in the opioid crisis.

Why it matters

The opioid epidemic has devastated communities across the country, with pharmacies playing a key role in the crisis. This settlement holds Albertsons accountable and provides much-needed resources for addiction treatment, prevention and community education in the affected areas.

The details

Albertsons operates 1,713 in-store pharmacies across a network of 2,244 retail food and drug stores in 35 states and the District of Columbia. The company stated the settlement is not an admission of wrongdoing or liability. The financial toll on the company has been substantial, with Albertsons recording a pre-tax charge of approximately $600 million last quarter, resulting in a reported operating loss of roughly $480 million. The settlement amount represents approximately 9% of the company's $8.66 billion market capitalization.

  • The settlement was announced on April 14, 2026.
  • The settlement will be paid out over nine years.

The players

Albertsons Companies, Inc.

A major pharmacy chain that operates 1,713 in-store pharmacies across a network of 2,244 retail food and drug stores in 35 states and the District of Columbia.

Levin Papantonio Proctor Buchanan O'Brien Barr & Mougey

A plaintiff law firm that has been a driving force in the National Prescription Opiate Litigation MDL, representing more than 750 local governments, 9 states and 15 tribes, and contributing to a recovery of more than $60 billion.

Peter Mougey

An attorney at Levin Papantonio who served on the court-appointed Plaintiffs' Executive Committee, leading negotiations in the opioid litigation.

Jeff Gaddy

An attorney at Levin Papantonio who has driven accountability against pharmacy chains across the country in the national opioid litigation.

Got photos? Submit your photos here. ›

What they’re saying

“This $774 million settlement sends a clear message: large pharmacy chains must take responsibility for their role in fueling the opioid crisis. This resolution represents meaningful accountability and will help provide tangible resources to those suffering from opioid abuse and addiction. We hope this settlement serves as both a measure of justice and a deterrent, ensuring that corporate actors prioritize patient safety over profit in the future.”

— Jeff Gaddy, Attorney, Levin Papantonio

What’s next

The settlement funds will be directed toward addiction treatment, prevention and community education for the states, counties and municipalities that bore the financial and human costs of the opioid epidemic.

The takeaway

This settlement represents a significant step in holding large pharmacy chains accountable for their role in the opioid crisis, providing much-needed resources to communities impacted by the epidemic. It serves as a deterrent, signaling that corporate profits should not come at the expense of public health and safety.